金陵药业上涨5.48%，报7.51元/股

Core Viewpoint - Jinling Pharmaceutical experienced a stock price increase of 5.48% on August 7, reaching 7.51 CNY per share, with a total market capitalization of 4.684 billion CNY [1] Group 1: Company Overview - Jinling Pharmaceutical Co., Ltd. is located at No. 58, Xinguang Avenue, Nanjing Economic and Technological Development Zone, primarily engaged in the pharmaceutical and health care industries [1] - The pharmaceutical segment has production capabilities for nearly a hundred varieties of Chinese and Western medicines, while the health care segment controls three comprehensive hospitals and one integrated health care project company [1] - The company was listed on the Shenzhen Stock Exchange in 1999, issuing 80 million A-shares, with the controlling shareholder being Nanjing New Industry Investment Group Co., Ltd. [1] Group 2: Financial Performance - As of February 10, Jinling Pharmaceutical had 37,100 shareholders, with an average of 15,900 circulating shares per person [2] - For the period from January to September 2024, the company achieved a revenue of 2.22 billion CNY, representing a year-on-year growth of 5.51% [2] - The net profit attributable to shareholders was 71.3687 million CNY, showing a year-on-year decrease of 26.88% [2]